Gender differences related to the presence of atrial fibrillation in older hypertensive patients

Table 1 Baseline characteristics of the study population, including biochemical, electrocardiogram and treatment data (mean ± SD) n (%)

Characteristics	Data
WBC, mm3	6727 ± 1774
Haemoglobin, g/dL	13.6 ± 1.8
Glucose, mg/dL	108 ± 31
LDL-cholesterol, mg/dL	118 ± 34
Triglycerides, mg/dL	129 ± 73
Uric acid, mg/dL	5.2 ± 1.1
Creatinine, mg/dL	0.97 ± 0.28
Glomerular filtration rate, mL/min	75 ± 22.5
Albumin/creatinine ratio	39.4 ± 109.8
Heart rate, bpm	71.7 ± 14
Normal QRS	794 (77.2)
Q waves	25 (2.4)
Sokolow LVH	15 (1.5)
Cornell LVH	103 (10)
Strain	84 (8.2)
Global LVH	177 (17.2)
Measurement of anti-HT	1.7 ± 0.87
Diuretics	535 (52.1)
Beta-blockers	240 (23.4)
Calcium antagonists	199 (19.4)
ACEI	265 (25.8)
ARB	611 (59.5)
Antiplatelet agents	196 (19.1)
VKA	72 (7.0)
No anti-HT drugs	62 (6)
Monotherapy	366 (35.6)
2 drugs	366 (35.6)
3 or more anti-HT drugs	234 (22.7)

WBC: White blood cell; LVH: Left ventricle hypertrophy; HT: Hypertension; ACEI: Angiotensin-converting enzyme inhibitors; ARB: Angiotensin receptor blocker; VKA: Vitamin K antagonist; LDL: Low-density lipoprotein.